Table 1.
Comparison of baseline characteristics between the comorbidity group and COPD group
| Variable | Comorbidity Group (n=133) | COPD Group (n=91) | Z/t/χ2 Value | P-Value |
|---|---|---|---|---|
| Age | 66.00 (63.00, 71.00) | 64.00 (62.50, 66.00) | 3.505 | <0.001 |
| ≥65 years | 89 | 41 | 9.259 | 0.002 |
| <65 years | 47 | 50 | ||
| Gender | 6.351 | 0.012 | ||
| Male | 122 | 73 | ||
| Female | 11 | 18 | ||
| BMI (kg/m2) | 22.91 (3.20) | 22.90 (3.35) | 0.014 | 0.989 |
| <18.5 | 11 | 10 | 0.569 | 0.752 |
| 18.5-24 | 75 | 48 | ||
| >24 | 47 | 33 | ||
| COPD Duration (years) | 11.00 (7.00, 16.00) | 8.00 (5.00, 12.00) | 3.197 | 0.001 |
| <10 | 55 | 56 | 11.038 | 0.004 |
| 45585 | 65 | 33 | ||
| >20 | 13 | 2 | ||
| Residence | 0.316 | 0.574 | ||
| Urban | 65 | 41 | ||
| Rural | 68 | 50 | ||
| Smoking History | 7.63 | 0.006 | ||
| Present | 108 | 59 | ||
| Absent | 25 | 32 | ||
| Drinking History | 1.436 | 0.231 | ||
| Present | 29 | 14 | ||
| Absent | 104 | 77 | ||
| Diabetes History | 0.031 | 0.861 | ||
| Present | 8 | 6 | ||
| Absent | 125 | 85 | ||
| Acute Exacerbation in Past Year | 1.632 | 0.201 | ||
| Present | 90 | 54 | ||
| Absent | 43 | 37 | ||
| Corticosteroid Treatment | 6.065 | 0.014 | ||
| Present | 20 | 26 | ||
| Absent | 113 | 65 | ||
| GOLD Staging | 24.804 | <0.001 | ||
| I | 18 | 2 | ||
| II | 79 | 37 | ||
| III | 34 | 46 | ||
| IV | 2 | 6 |
Note: BMI: Body Mass Index, COPD: Chronic Obstructive Pulmonary Disease, GOLD: Global Initiative for Chronic Obstructive Lung Disease.